Genbiopro, INC.
Generic Pharmaceutical Manufacturer
Based in NV
🤖
AI Overview
With $500K in lobbying spend across 15 quarterly filings, Genbiopro, INC is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2022 to 2025.
$500K
Total Spend
4
Years Active
1
Firms Hired
2
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2022 | $80K |
| 2023 | $140K |
| 2024 | $140K |
| 2025 | $140K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Pharmacy, Family Issues, Veterans
- •Issues related to medication abortion Issues related to abortion access Issues related to FDA Approval of Mifepristone
- •FDA Approval of generic mifepristone and related Risk Evaluation Mitigation Strategies (REMS).
- •VA rulemaking on providing abortion services to veterans.
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
National Council of Juvenile and Family Court Judges
$296K total spend
Westcare Foundation
$180K total spend
Integrative Providers Association
$0 total spend
Mckesson Corporation & Affiliates U.S. Oncology and Rx Savings Solutions
$22.7M total spend
Ascension Health Alliance D/B/A Ascension
$12.8M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.